Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021

SELL
$6.78 - $9.04 $108,337 - $144,450
-15,979 Closed
0 $0
Q1 2021

May 14, 2021

SELL
$8.18 - $23.98 $12,245 - $35,898
-1,497 Reduced 8.57%
15,979 $135,000
Q4 2020

Feb 02, 2021

SELL
$15.81 - $29.0 $346,539 - $635,651
-21,919 Reduced 55.64%
17,476 $385,000
Q3 2020

Nov 05, 2020

BUY
$18.75 - $28.58 $15,000 - $22,864
800 Added 2.07%
39,395 $801,000
Q2 2020

Aug 12, 2020

BUY
$15.6 - $54.87 $602,082 - $2.12 Million
38,595 New
38,595 $1.07 Million

Others Institutions Holding IMRA

About IMARA Inc.


  • Ticker IMRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,287,300
  • Market Cap $552M
  • Description
  • IMARA Inc., a clinical-stage biopharmaceutical company, develops and commercializes therapeutics for patients with rare genetic disorders of hemoglobin. Its lead product candidate is IMR-687, an oral and once-a-day therapeutic that is in Phase 2b clinical trials for the treatment of sickle cell disease and ß-thalassemia. The company also develop...
More about IMRA
Track This Portfolio

Track California Public Employees Retirement System Portfolio

Follow California Public Employees Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.